Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Biological Efficacy Study of HerpV Vaccine With QS-21 to Treat Subjects With Recurrent Genital Herpes

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Agenus Inc.
ClinicalTrials.gov Identifier:
NCT01687595
First received: September 12, 2012
Last updated: January 12, 2015
Last verified: January 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2015
  Primary Completion Date: September 2013 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: January 12, 2015